145
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Cytopathology and Polymerase Chain Reaction of Vitreous Fluid in Tubercular Intermediate Uveitis

, MS & , MS
Pages 854-856 | Received 22 Jul 2019, Accepted 22 Nov 2019, Published online: 06 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Soumen Sadhu, Rupesh Agrawal, Richa Pyare, Carlos Pavesio, Manfred Zierhut, Anadi Khatri, Justine R. Smith, Marc D de Smet & Jyotirmay Biswas. (2020) COVID-19: Limiting the Risks for Eye Care Professionals. Ocular Immunology and Inflammation 28:5, pages 714-720.
Read now

Articles from other publishers (3)

E. B. Tatarnikova, O. I. Krivosheina & E. V. Ivanova. (2022) Modern etiological and pathogenetic aspects of chronic peripheral uveitis. Medical Immunology (Russia) 24:1, pages 31-40.
Crossref
Rosario Gulias-Cañizo, Estela D'Abril Ruíz-Leyja, Valeria Sánchez-Huerta & Lenin Ochoa-de la Paz. (2021) SARS-CoV-2 and the Eye: A Relationship for a Possible Prognostic Tool in COVID-19 Patients. Clinical Ophthalmology Volume 15, pages 707-712.
Crossref
Ranju Kharel Sitaula, Anadi Khatri, MK Janani, Rajendra Mandage, Soumen Sadhu, HN Madhavan, Madan Prasad Upadhyay & Jyotirmay Biswas. (2020) <p>Unfolding COVID-19: Lessons-in-Learning in Ophthalmology</p>. Clinical Ophthalmology Volume 14, pages 2807-2820.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.